Filing Details

Accession Number:
0000899243-20-012297
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-07 19:12:43
Reporting Period:
2020-05-05
Accepted Time:
2020-05-07 19:12:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563577 Galera Therapeutics Inc. GRTX Pharmaceutical Preparations (2834) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1227367 T Jon Holmlund C/O Galera Therapeutics, Inc.,
2 W Liberty Blvd #100
Malvern PA 19355
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-05 3,064 $1.07 3,064 No 4 M Direct
Common Stock Disposition 2020-05-05 3,064 $12.16 0 No 4 S Direct
Common Stock Acquisiton 2020-05-06 1,489 $1.07 1,489 No 4 M Direct
Common Stock Disposition 2020-05-06 1,489 $12.00 0 No 4 S Direct
Common Stock Acquisiton 2020-05-07 2,059 $1.07 2,059 No 4 M Direct
Common Stock Disposition 2020-05-07 2,059 $12.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2020-05-05 3,064 $0.00 3,064 $1.07
Common Stock Stock Option Disposition 2020-05-06 1,489 $0.00 1,489 $1.07
Common Stock Stock Option Disposition 2020-05-07 2,059 $0.00 2,059 $1.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,345 2023-01-22 No 4 M Direct
15,856 2023-01-22 No 4 M Direct
13,797 2023-01-22 No 4 M Direct
Footnotes
  1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019.
  2. The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $12.00 to $12.62. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $12.00 to $12.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The option has fully vested and is currently exercisable.